Seroprevalence of SARS-CoV-2 infection among healthcare personnel in Gran Santa Fe (Argentina) during the COVID-19 pandemic
DOI:
https://doi.org/10.24265/horizmed.2025.v25n1.03Keywords:
Seroepidemiologic Studies , SARS-CoV-2 , Health PersonnelAbstract
Objective: To estimate the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection through antibody detection among healthcare personnel (HP) in Gran Santa Fe (Argentina) during virus sustained circulation and remission phases. Materials and methods: A longitudinal, population-based, seroepidemiological study was conducted. The target population consisted of HP working in second- and third-level public health centers in the Gran Santa Fe region. The sample comprised 600 active health workers, proportionally distributed across selected health centers. A self-administered questionnaire collected data on sociodemographic, occupational, clinical and exposure variables of interest. IgG and IgM antibodies to SARS-CoV-2 were detected from serum samples using indirect enzyme-linked immunoassays. Results: The prevalence of IgG antibodies to SARS-CoV-2 was 7.6 times higher during the virus circulation phase compared to the remission phase (2.1 % vs. 15.9 %, respectively), while no IgM antibodies were detected. Regarding the level of workplace exposure risk, the highest cumulative prevalence, 26.7 %, was observed in the high-risk group (workers in direct contact with patients and “assigned to the Intensive Care Unit [ICU]” or “assigned to the COVID-19 Area” or “assigned to the Emergency Department”). Nearly one-third of workers reported inconsistent use of recommended personal protective equipment (PPE), and fewer than 10 % reported full adherence to PPE guidelines, regardless of the level of exposure risk. The seroprevalence among HP who reported no symptoms since the beginning of the Aislamiento Social Preventivo y Obligatorio (Preventive and Mandatory Lockdown) was 12.3 % during the remission phase, compared to 10.0 % among HP with a history of negative RT-PCR results (p < 0.05). Conclusions: Complementing passive epidemiological surveillance with active serological surveillance using simple and cost-effective tests is important for accurately tailoring mitigation strategies in vulnerable populations such as HP.
Downloads
References
Organización Mundial de la Salud. Cronología de la respuesta de la OMS a la COVID-19 [Internet]. Ginebra: OMS; 2020. Disponible en: https://www.who.int/es/news/item/29-06-2020-covidtimeline
World Health Organization. Coronavirus disease (COVID-19) Epidemiological Updates and Monthly Operational Updates [Internet]. Ginebra: WHO; 2020. Disponible en: https://www.who. int/emergencies/diseases/novel-coronavirus-2019/situation-reports Ministerio de Salud Argentina.
COVID-19: Evaluación de riesgos y manejo de trabajadores de la salud expuestos a COVID-19 [Internet]. Argentina: Ministerio de Salud Argentina: 2020. Disponible en: https://bancos.salud.gob.ar/sites/default/files/2020-08/covid19evaluacion-de-riesgos-y-manejo-de-trabajadores-salud-expuestos.pdf Organización Mundial de la Salud.
Protocolo de evaluación de los posibles factores de riesgo de enfermedad por coronavirus 2019 (COVID 19) para los trabajadores de salud en entornos sanitarios [Internet]. Ginebra: OMS; 2020. Disponible en: https://www.who. int/publications/i/item/protocol-for-assessment-of-potential-riskfactors-for-2019-novel-coronavirus-(2019-ncov)-infection-amonghealth-care-workers-in-a-health-care-setting
Mhango M, Dzobo M, Chitungo I, Dzinamarira T. COVID-19 risk factors among health workers: a rapid review. Saf Health Work [Internet]. 2020;11:262-5.
Barrett ES, Horton DB, Roy J, Gennaro ML, Brooks A, Tischfield J, et al. Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic. BMC Infect Dis [Internet]. 2020;20:853.
Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo C-G, Ma W, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health [Internet]. 2020;5:e475-83.
Alberta Health Service. COVID-19 Scientific advisory group rapid response report [Internet]. Alberta: AHS; 2020. Disponible en: https://www.albertahealthservices.ca/assets/info/ppih/if-ppihcovid-19-sag-risk-prediction-tools-rapid-review.pdf
World Health Organization. Coronavirus disease (COVID-19) technical guidance: early investigations protocols [Internet]. Ginebra: WHO; 2020. Disponible en: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/technical-guidance/early-investigations
Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, TaylorPhillips S, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database of Syst Rev [Internet]. 2020;6:CD013652.
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENECOVID): a nationwide, population-based seroepidemiological study. Lancet [Internet]. 2020;396:535-44.
Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). COVID-19 serology surveillance strategy [Internet]. Atlanta: CDC; 2020. Disponible en: https://stacks.cdc.gov/view/cdc/88069/ cdc_88069_DS1.pdf
Organización Mundial de la Salud. Vigilancia de salud pública en relación con la COVID-19: Orientaciones provisionales [Internet]. Ginebra: OMS; 2020. Disponible en: https://apps.who.int/iris/bitstream/ handle/10665/334000/WHO-2019-nCoV-SurveillanceGuidance2020.7-spa.pdf?sequence=1&isAllowed=y
Organización Mundial de la Salud. Protocolos de serología e investigación temprana [Internet]. Ginebra: OMS; 2020. Disponible en: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/technical-guidance/early-investigations
Ministerio de Salud de la Nación. Ficha de notificación, investigación epidemiológica y solicitud de estudios de laboratorio de caso sospechosos de nuevo coronavirus COVID-19 [Internet]. Buenos Aires: Ministerio de Salud de la Nación; 2020. Disponible en: https://www. argentina.gob.ar/sites/default/files/ficha-coronavirus.pdf
Organización Mundial de la Salud. Guía sobre la reglamentación relativa al transporte de sustancias infecciosas 2019–2020 [Internet]. Ginebra: OMS; 2019. Disponible en: https://www.who.int/es/ publications/i/item/WHO-WHE-CPI-2019-20
Consejo Nacional de Investigaciones Científicas y Técnica. Enzimoinmunoensayo (ELISA) para la detección de anticuerpos IgG específicos contra el virus SARS-CoV-2 en suero o plasma humano [Internet]. Buenos Aires: CONICET; 2020. Disponible en: https:// portal-coronavirus.gba.gob.ar/sites/default/files/Inserto%20KIT%20 COVID%20AR%20IgG.pdf
Gobierno de la Provincia de Santa Fe. COVID-19: Protocolos y recomendaciones [Internet]. Argentina: Gobierno de la Provincia de Santa Fe; 2021. Disponible en: https://www.santafe.gob.ar/ms/ covid19/protocolos-y-recomendaciones/
East S, Laurence T, López Mourelo E. COVID-19 y la situación de las trabajadoras de la salud en Argentina [Internet]. Argentina: OIT;2020. Disponible en: https://lac.unwomen.org/sites/default/files/ Field%20Office%20Americas/Documentos/Publicaciones/2020/08/ Trabajadoras%20de%20la%20salud_COVID19.pdf
Silva AP, Aguirre MF, Ballejo C, Marro MJ, Gamarnik A, Vargas G, et al. Seroprevalencia de infección por SARS-CoV-2 en personal de salud de la Región Sanitaria VIII, provincia de Buenos Aires. Rev Argent Salud Publica [Internet]. 2020;12:1-9.
Plebani M, Padoan A, Fedeli U, Schievano E, Vecchiato E, Lippi G, et. al. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin Chem Lab Med [Internet]. 2020;58(12): 2107-11.
Chibwana MG, Jere KC, Kamng’ona R, Mandolo J, Katunga-Phiri V, Dumizulu Tembo D, et. al. High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi. MedRxiv [Internet]. 2020;5:199.
Rudberg AS, Havervall S, Manberg A, Falk AJ, Aguilera K, Ng H. SARSCoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun [Internet]. 2020;11: 5064.
Chafloque-Vásquez R, Pampa-Espinoza L, Celis Salinas JC. Seroprevalencia de COVID-19 en trabajadores de un hospital de la Amazonía peruana. Acta Med Peru [Internet]. 2020;37(3):390-2.
Alkurt G, Murt A, Aydin Z, Tatli O, Agaoglu NB, Irvem A, et al. Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey. PLoS ONE [Internet]. 2021;16(3):e0247865.
Shields A, Faustini SE, Perez-Toledo M, Jossi S, Aldera E, Allen JD, et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax [Internet]. 2020;75:1089-94.
Mhango M, Dzobo M, Chitungo I, Dzinamarira T. COVID-Risk Factors Among Health Workers. Saf Health Work [Internet]. 2020;11:262-5.
Alberta Health Services. COVID-19: Risk to Healthcare Workers. COVID-19 Scientific Advisory Group Rapid Response Report. Alberta: AHS;2020. Disponible en: https://www.albertahealthservices. ca/assets/info/ppih/if-ppih-covid-19-sag-rapid-evidence-reportmasking-guidance-healthcare-workers.pdf
Wu X, Fu B, Chen L, Feng Y. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China. J Med Virol [Internet]. 2020;92(10):1795-6.
Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis [Internet]. 2020;20(4):410-1.
Published
How to Cite
Issue
Section
License
Copyright (c) 1970 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
